Asthma and allergy medication use and costs among pediatric primary care patients on asthma controller therapy

被引:6
|
作者
Sazonov-Kocevar, Vasilisa
Laforest, Laurent
Travier, Noemie
Yin, Donald D.
Van Ganse, Eric
机构
[1] Merck & Co Inc, Whitehouse Stn, NJ USA
[2] Hop Lyon Sud, Unite Pharmcoepidemiol, Pierre Benite, France
关键词
asthma; children; control; costs; medication use;
D O I
10.1111/j.1399-3038.2006.00459.x
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
As observational studies in children initiating GINA-Step 3 therapies are scarce, we evaluated outcomes and costs in a primary care cohort. Two-yr retrospective cohort study included French children (age: 6-14) continuously followed in BKL-Thales database who received >= 2 consecutive prescriptions for GINA-Step 3 therapy (=addition of montelukast or other controllers ('other'), such as increasing inhaled-corticosteroid dose (hICS), adding long-acting beta agonist (LABA), or ICS + LABA). After matching on gender and propensity score, medication use [rescue (short-acting beta agonists), acute (antibiotics (AB), oral corticosteroids (OCS)), allergy (antihistamines, nasal steroids) and other respiratory] was estimated via mean number of prescriptions and mean cost (per child/per month), and cost trends. During 12-month follow-up, children adding montelukast (n = 71) vs. 'other' (n = 213) had similar asthma rescue/acute and allergy medication use. Subgroup with asthma and allergic rhinitis (A + AR) adding montelukast used less OCS and AB (p = 0.014). Two-yr cost trends suggest stable asthma/allergy medication use in montelukast group (e0.83) compared with increase in 'other' (e5.39), which was driven by nasal steroid use [e0.32 ('other') vs. e-0.04 (montelukast), p = 0.0013]. In subgroup with A + AR decline in asthma/allergy medication use in montelukast group (e-0.47) vs. increase in 'other' (e11.05), p = 0.015, was driven by differences in AB and OCS (p = 0.04) and nasal steroid use (p = 0.001). Concomitant asthma/allergy medication use was similar in children adding montelukast or 'other' controllers (hICS, LABA, ICS + LABA), while children with allergic rhinitis on montelukast used less AB. Concomitant medication costs after addition of montelukast remained stable, while 'other' group experienced increase, especially in children with concomitant allergic rhinitis.
引用
收藏
页码:620 / 628
页数:9
相关论文
共 50 条
  • [21] Mismatching Among Guidelines, Providers, and Parents on Controller Medication Use in Children with Asthma
    Wu, Ann Chen
    Li, Lingling
    Fung, Vicki
    Kharbanda, Elyse O.
    Larkin, Emma K.
    Butler, Melissa G.
    Galbraith, Alison
    Miroshnik, Irina
    Davis, Robert L.
    Horan, Kelly
    Lieu, Tracy A.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2016, 4 (05): : 910 - 916
  • [22] Severe Asthma, Uncontrolled Asthma, And The Use Of Triple Controller Therapy For Asthma In China
    Wang, G.
    Gibson, P. G.
    Wang, F.
    Guo, M.
    Zhang, W.
    Gao, P.
    Zhang, H.
    Harvey, E.
    Li, H.
    Zhang, J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [23] Asthma medication use and disease burden in children in a primary care population
    Lozano, P
    Hecht, J
    Shulruff, R
    Weiss, KB
    ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 2003, 157 (01): : 81 - 88
  • [24] SABA and ICS use among mild asthma patients in UK primary care
    Bloom, Chloe
    Quint, Jennifer
    Cabrera, Claudia
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [25] Pediatric Asthma for the Primary Care Practitioner
    VanGarsse, Anne
    Magie, Richard D.
    Bruhnding, Aubree
    PRIMARY CARE, 2015, 42 (01): : 129 - +
  • [26] Pediatric Asthma for the Primary Care Physician
    Gray, Kevin W.
    PRIMARY CARE, 2021, 48 (03): : 379 - 394
  • [27] Time and Risk Preferences and the Use of Asthma Controller Medication
    Brandt, Sylvia
    Dickinson, Brenton
    PEDIATRICS, 2013, 131 (04) : E1204 - E1210
  • [28] Racial Disparities in Asthma Morbidity Among Pediatric Patients Seeking Asthma Specialist Care
    Mitchell, Stephanie J.
    Bilderback, Andrew L.
    Okelo, Sande O.
    ACADEMIC PEDIATRICS, 2016, 16 (01) : 64 - 67
  • [29] Medication use and health care contacts among symptomatic children with asthma
    Halterman, JS
    Yoos, HL
    Sidora, K
    Kitzman, H
    McMullen, A
    AMBULATORY PEDIATRICS, 2001, 1 (05) : 275 - 279
  • [30] Health-care utilization and costs in Taiwanese pediatric patients with asthma
    Sun, Hai-Lun
    Kao, Yea-Huei
    Lu, Tsung-Hsueh
    Chou, Ming-Chieh
    Lue, Ko-Huang
    PEDIATRICS INTERNATIONAL, 2007, 49 (01) : 48 - 52